A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer
Clinical trial NCT02133742 · COMPLETED
Trial details
- NCT number
- NCT02133742
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-16
- Primary completion
- 2017-03-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.